i don't believe this is only related to the patent ANN. we have seen many times with just a patent ANN out there, that's kinda fluffy and not kicking anything. this is something else.
keep it in mind that one of the LAG525 trials on Novartis board, with 490 pts of solid tumor, is due for full completion on 22nd July which is next Wed.
- Forums
- ASX - By Stock
- IMM
- Ann: US patent granted for IMP701 antibody
Ann: US patent granted for IMP701 antibody, page-21
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $458.1M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 30.8¢ | $684.8K | 2.183M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 436502 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 92443 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 436502 | 0.310 |
11 | 500761 | 0.305 |
3 | 59923 | 0.300 |
3 | 48751 | 0.295 |
3 | 66656 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 92443 | 1 |
0.320 | 286003 | 12 |
0.325 | 279080 | 6 |
0.330 | 44346 | 4 |
0.335 | 70407 | 5 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online